TOVX vs WST · rev $300.0K vs P/E 35, rev $1.72B
Theriva Biologics Inc. (TOVX) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Latest reported WST revenue for 2026-06-30 was $1.72B. Net income was $292.8M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
TOVX currently screens at market cap $12.4M. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the TOVX and WST stock pages for the full models.
Not investment advice.